Parenting Skills for Mothers With Borderline Personality Disorder (BPD) (ProChild)

February 4, 2020 updated by: Babette Renneberg, Freie Universität Berlin

Preventing Maltreatment and Promoting Mental Health in Children of Mothers With Borderline Personality Disorder - ProChild

The first disorder-specific parenting training program for mothers with Borderline Personality Disorder (M-BPD) is evaluated in a randomized controlled trial.

The training program is expected to have positive effects on parenting behavior, decrease the risk of maltreatment of the child, and improve emotion regulation in mothers at post treatment and at 6-month follow-up compared to a control group (treatment as usual; TAU).

Additionally, disorder-specific aspects of dysfunctional parenting behavior as well as BPD-specific aspects of child maltreatment are compared to a clinical control group (mothers with anxiety and/or depression, M-AD/D) and a healthy control group (M-CON).

To assess the differential development of parenting, the risk of maltreatment and emotion dysregulation in untreated M-BPD are compared to M-CON. The investigators expect the difference to increase over time, indicating a worsening in BPD parenting.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

240

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Berlin, Germany
        • Recruiting
        • Freie Universität Berlin
        • Contact:
          • Anne Trösken

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion criteria for mothers with BPD:

  1. diagnosed with BPD (assessed via SCID-PD)
  2. running or completed therapy for BPD symptoms
  3. child between 6 months and 6 years
  4. living with child or regular (weekly) contact

Exclusion criteria for the mothers with BPD

  1. Acute child endangerment
  2. maternal acute suicidality
  3. maternal psychotic symptoms (assessed via SCID-CV)
  4. maternal acute alcohol or drug dependency (assessed via SCID-CV)
  5. maternal diagnosed intellectual disability.

Inclusion criteria for mothers with depression and/or anxiety disorders:

  1. diagnosed with acute affective or anxiety disorder (assessed via SCID-CV)
  2. child between 6 months and 6 years
  3. living with child or regular (weekly) contact

Exclusion criteria for mothers with depression and/or anxiety disorders:

  1. Acute child endangerment
  2. maternal acute suicidality
  3. maternal psychotic symptoms (assessed via SCID-CV)
  4. maternal acute alcohol or drug dependency (assessed via SCID-CV)
  5. maternal diagnosed intellectual disability
  6. lifetime diagnosis of BPD (assessed via SCID-PD)

Inclusion criteria for healthy control group:

  1. child between 6 months and 6 years
  2. living with child or regular (weekly) contact

Exclusion criteria for the healthy control group:

  1. Acute child endangerment
  2. maternal acute suicidality
  3. maternal psychotic symptoms (assessed via SCID-CV)
  4. maternal acute alcohol or drug dependency (assessed via SCID-CV)
  5. maternal diagnosed intellectual disability.
  6. lifetime diagnosis of BPD (assessed via SCID-PD)
  7. any acute mental disorder (assessed via SCID-CV)
  8. current psychotherapy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group (BPD)
Participants (N=60) receive the weekly conducted intervention (group training for mothers with BPD) over the period of 12 weeks (12 sessions). Assessments of each participant: T0 (pre-intervention), T1 (post-intervention) and follow-up (6 months after T1).
The group programme is designed to teach mothers with BPD parenting skills and to reduce dysfunctional parenting attitudes and strategies. The components are: childrens basics needs, mindfulness, stress and stress reduction, dealing with conflicts, dealing with emotions, dysfunctional attitudes, physical contact, parenting rules, self care.
No Intervention: waiting control group (BPD)
Members of this group (N=60) receive no intervention but treatment as usual (TAU). After completing all assessment points (T0, T1, T2), they can receive the intervention of the intervention group (group training).
No Intervention: clinical control group (AD/MDD)
Mothers with anxiety and/or depression (N=60) receive no intervention. Assessment point only T0.
No Intervention: healthy control group
Mothers with no actual mental disorder (N=60) receive no intervention.# Assessment points T0, T1, T2.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in dysfunctional discipline practices
Time Frame: day 0 (before treatment), week 12 (after treatment), month 9 (6 months after second assessment)
Parenting Scale (Arnold, O'Leary, Wolff & Acker, 1993; german version: Erziehungsfragebogen-Kurzform, EFB-K; Miller, 2001). Questionniare measuring dysfunctional discipline practices in parents. Mean values range between 1-7 with higher values indicating more negative parenting strategies.
day 0 (before treatment), week 12 (after treatment), month 9 (6 months after second assessment)
Change in positive and dysfunctional parenting strategies
Time Frame: day 0 (before treatment), week 12 (after treatment), month 9 (6 months after second assessment)
Alabama Parenting Questionnaire (Frick, 1991; German DEAPQ-EL-GS; Reichle & Franiek, 2007). The questionnaire assesses several parenting strategies with 7 subscales (positive parenting, responsible parenting, parental Involvement, poor monitoring/supervision, inconsistent discipline, corporal punishment, powerful implementation). Range 6-30, with higher values indicating more of the respective parenting strategy
day 0 (before treatment), week 12 (after treatment), month 9 (6 months after second assessment)
Change in child rearing competence
Time Frame: day 0 (before treatment), week 12 (after treatment), month 9 (6 months after second assessment)
Parenting Sense of Competence Scale (PSOC, Gibeau- Wallston & Wandersman, 1978; German FKE; Miller, 2001). The PSOC measures how parents perceive their child rearing competence. Range 0-96 with higher values indicating higher sense of competence.
day 0 (before treatment), week 12 (after treatment), month 9 (6 months after second assessment)
Change in parental stress
Time Frame: day 0 (before treatment), week 12 (after treatment), month 9 (6 months after second assessment)
Parental Stress Index (PSI, Abidin, 1995; German EBI; Tröster, 2010). The PSI is a dimensional rating of parental stress. Range 48 - 240 with higher values indicating higher stress.
day 0 (before treatment), week 12 (after treatment), month 9 (6 months after second assessment)
Change in physical and psychological aggression towards child
Time Frame: day 0 (before treatment), week 12 (after treatment), month 9 (6 months after second assessment)
Conflict Tactic Scale - Parent Child (CTS-PC; Strauss, 1998). The CTSPC measures the extent to which a parent has carried out specific acts of physical and psychological aggression. Range 0-300 with higher values indicating higher annual frequency
day 0 (before treatment), week 12 (after treatment), month 9 (6 months after second assessment)
Change in physical abuse potential
Time Frame: day 0 (before treatment), week 12 (after treatment), month 9 (6 months after second assessment)
Child Abuse Potential Inventory (CAPI, Milner, 1986, German EBSK; Deegener et al., 2009). The CAPI measures physical abuse potential with reference to the individual burden and three validity scales: a lie scale, a random response scale, and an inconsistency scale. t-values are calculated considering all scales.
day 0 (before treatment), week 12 (after treatment), month 9 (6 months after second assessment)
Change in child neglect
Time Frame: day 0 (before treatment), week 12 (after treatment), month 9 (6 months after second assessment) and for the intervention group after each session.
Child Neglect Index (CNI; Trocmé, 1996). The CNI measures child neglect, rated by the diagnostician. Range 0-80 with higher values indicating higher neglect.
day 0 (before treatment), week 12 (after treatment), month 9 (6 months after second assessment) and for the intervention group after each session.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in emotion regulation
Time Frame: day 0 (before treatment), week 12 (after treatment), month 9 (6 months after second assessment)
Difficulties in Emotion Regulation Scale (DERS; Gratz & Roemer, 2004). Difficulties in emotion regulation are measured with a) awareness and understanding of emotions; (b) acceptance of emotions; (c) the ability to engage in goal-directed behavior, and refrain from impulsive behavior, when experiencing negative emotions; and (d) access to emotion regulation strategies perceived as effective. Range 36 - 180 with higher values indicating more problems in emotion regulation.
day 0 (before treatment), week 12 (after treatment), month 9 (6 months after second assessment)
Change in mental distress
Time Frame: day 0 (before treatment), week 12 (after treatment), month 9 (6 months after second assessment)
Brief Symptom Inventory (BSI, Derogatis, 1975; German: Franke, 2000). The BSI measures mental distress. Results are displayed via t-values.
day 0 (before treatment), week 12 (after treatment), month 9 (6 months after second assessment)
Change in borderline specific thoughts and feelings
Time Frame: day 0 (before treatment), week 12 (after treatment), month 9 (6 months after second assessment)
Questionnaire of Thoughts and Feelings (QTF, Renneberg et al., 2010). The QTF measures borderline specific thoughts and feelings. Range 1-5 with higher values indicating more BPD-specific thoughts and feelings.
day 0 (before treatment), week 12 (after treatment), month 9 (6 months after second assessment)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Negative intervention outcomes
Time Frame: week 12 (after treatment) (intervention group only)
Questionniare assessing negative intervention outcomes (INEP, Ladwig, Rief, & Nestoriouc, 2014).The INEP measures negative effects of psychotherapy in different areas of life (intrapersonal change, relationships, friendships, family, malpractice, and stigmatization). Range from -3 to +3. Higher values indicating better therapeutic course.
week 12 (after treatment) (intervention group only)
client satisfaction
Time Frame: week 12 (after treatment) (intervention group only)
Client Satisfaction Questionnaire (CSQ-8, Attkisson & Zwick, 1982; German ZUF-8; Schmidt, Lamprecht & Wittmann, 1989). CSQ-8 measures client satisfaction with intervention. Range 8-32 with higher values indicating greater satisfaction.
week 12 (after treatment) (intervention group only)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Babette Renneberg, Prof., Freie Universität Berlin

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 4, 2020

Primary Completion (Anticipated)

June 1, 2022

Study Completion (Anticipated)

March 1, 2023

Study Registration Dates

First Submitted

October 24, 2019

First Submitted That Met QC Criteria

November 18, 2019

First Posted (Actual)

November 19, 2019

Study Record Updates

Last Update Posted (Actual)

February 5, 2020

Last Update Submitted That Met QC Criteria

February 4, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • RenRos02

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Borderline Personality Disorder

Clinical Trials on Group training for mothers with Borderline Personality Disorder

3
Subscribe